A multicenter, randomized, double-blind, placebo-controlled study of tolvaptan monotherapy compared to furosemide and the combination of tolvaptan and furosemide in patients with heart failure and systolic dysfunction
Phase of Trial: Phase II
Latest Information Update: 01 Dec 2011
At a glance
- Drugs Tolvaptan (Primary) ; Furosemide
- Indications Heart failure
- Focus Pharmacodynamics
- 01 Dec 2011 Results published in the Journal of Cardiac Failure.
- 05 Nov 2010 New trial record.